Clinical Cardiac Rehabilitation Registry Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 2,081
- 试验地点
- 1
- 主要终点
- All-cause and attributed deaths
研究概览
简要总结
Establish an electronic cardiac rehabilitation patient registration system and clinical database, carry out prospective cohort follow-up and observation of cardiovascular disease (CVD) patients receiving cardiac rehabilitation in inpatients and outpatients, collect risk factors, diagnosis and treatment status, rehabilitation diagnosis and treatment, clinical outcomes and follow-up results, and establish a short-term and long-term follow-up mechanism.
详细描述
Establish an electronic cardiac rehabilitation patient registration system and clinical database, carry out prospective cohort follow-up and observation of cardiovascular disease (CVD) patients receiving cardiac rehabilitation in inpatients and outpatients, collect risk factors, diagnosis and treatment status, rehabilitation diagnosis and treatment, clinical outcomes and follow-up results, and establish a short-term and long-term follow-up mechanism. Through the real world clinical practice data of cardiac rehabilitation of CVD patients, describe the population and disease characteristics of cardiac rehabilitation patients, the provision of cardiac rehabilitation services and the influencing factors; Analyze and study the key technologies of clinical cardiac rehabilitation, evaluate the implementation quality of cardiac rehabilitation, improve the clinical pathway of cardiac rehabilitation, and optimize the service process.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age and older.
- •Patients receiving inpatient cardiac rehabilitation, and/or participating in outpatient cardiac rehabilitation.
- •All cases selected were in New York Heart Association (NYHA) cardiac function class II and below.
- •Normal troponin.
- •Patients with some ability to communicate and understand.
- •have signed an informed consent form. -
排除标准
- •Subjects who are participating in clinical trials of other drugs or devices.
- •Patients with NYHA cardiac function class III or higher.
- •Mentally impaired, or unable to communicate effectively with investigators.
- •Refusal to sign the informed consent form.
结局指标
主要结局
All-cause and attributed deaths
时间窗: 1-year and 2-year
All-cause and attributed deaths during hospitalization and follow-up of CVD patients
Major adverse cardiovascular events (MACE) occurrence
时间窗: 1-year and 2-year
Major adverse cardiovascular events (MACE) occurrence include cardiovascular death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemia-driven revascularization.
次要结局
- Cardiopulmonary function and quality of life(1-year and 2-year)
- Participation and adherence(1-year and 2-year)
- Medical costs of cardiac rehabilitation patients during hospitalization and up to 2 years after discharge.(1-year and 2-year)
- Proportion of different comorbidities, interactions and prognosis in CVD.(1-year and 2-year)